Beneficiary 5: EDI

University of Edinburgh (EDI)

Scientist in Charge: Asier Unciti-Broceta

The University of Edinburgh is the leading research university in Scotland and also is amongst the top ten in the United Kingdom with an international reputation as a centre of academic excellence. The THERACAT project will be performed at the Cancer Research UK Edinburgh Centre (CRUK-EC), which sits within the Institute of Genetics and Molecular Medicine (IGMM), one of the largest centres internationally for human genetics, molecular medicine & cancer research with >500 research staff.

The Innovative Therapeutics Lab led by Professor Asier Unciti-Broceta  explores novel chemical strategies to improve the efficacy and safety of cancer treatments. This includes development of highly-selective inhibitors of kinases involved in cancer and novel prodrug strategies aimed at improving the clinical use of well-established chemotherapy drugs.